The FDA elevated a prior recall of implantable pain pump tubing to Class I after additional reports of under-delivery events.
The manufacturer is contacting patients and providers to arrange replacements and monitoring.
Clinicians are advised to check documentation against the listed lot numbers before any refill procedure.